The Former Attorney General of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors of Lead Plaintiff Deadline in Class ...
January 15 2016 - 10:00PM
Business Wire
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former
Attorney General of Louisiana, Charles C. Foti, Jr., remind
investors that they have until March 14, 2016 to file lead
plaintiff applications in a securities class action lawsuit against
Esperion Therapeutics, Inc. (NasdaqGM: ESPR), if they purchased the
Company’s securities between August 18, 2015 through September 28,
2015, inclusive (the “Class Period”). This action is pending in the
United States District Court for the Eastern District of
Michigan.
What You May Do
If you purchased shares of Esperion and would like to discuss
your legal rights and how this case might affect you and your right
to recover for your economic loss, you may, without obligation or
cost to you, call toll-free at 1-877-515-1850 or email KSF Managing
Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to serve
as a lead plaintiff in this class action, you must petition the
Court by March 14, 2016.
About the Lawsuit
Esperion and certain of its executives are charged with failing
to disclose material information during the Class Period, violating
federal securities laws.
The alleged false statements and omissions include, in part,
that: (i) there was no clear path to approval for ETC-1002, a
once-daily small molecule designed to lower LDL-cholesterol levels
while avoiding the side effects associated with other
LDL-cholesterol lowering therapies on the market; (ii) the FDA had
encouraged Esperion Therapeutics to initiate a cardiovascular
outcomes trial (“CVOT”); and (iii) completion of a CVOT could be
necessary prior to approval of ETC-1002.
About Kahn Swick & Foti, LLC
KSF, whose partners include the Former Louisiana Attorney
General Charles C. Foti, Jr., is a law firm focused on securities,
antitrust and consumer class actions, along with merger &
acquisition and breach of fiduciary litigation against publicly
traded companies on behalf of shareholders. The firm has offices in
New York, California and Louisiana.
To learn more about KSF, you may visit www.ksfcounsel.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160115005947/en/
Kahn Swick & Foti, LLCLewis Kahn, Managing Partner,
1-877-515-1850lewis.kahn@ksfcounsel.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024